MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

Cash & Equivalents

$19.30B

Quarterly · Period ending: · USD

MLG logo

MLG Cash & Equivalents

Latest reported$19.30B
MLG Quarterly Cash & Equivalents ($5.05B → $19.30B)
High-resolution chart · PNG

MLG cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

MetLife, 5.875% Senior Notes due 11/21/2033 Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
19,301,000,000
22,687,000,000
22,032,000,000
20,233,000,000
22,178,000,000
21,326,000,000
20,068,000,000
21,765,000,000
20,786,000,000
19,840,000,000
20,639,000,000
14,912,000,000
15,417,000,000
18,456,000,000
20,195,000,000
22,200,000,000
20,548,000,000
23,488,000,000
20,047,000,000
18,956,000,000
25,037,000,000
19,635,000,000
19,795,000,000
24,405,000,000
24,289,000,000
24,094,000,000
16,598,000,000
19,452,000,000
18,435,000,000
14,506,000,000
15,821,000,000
12,490,000,000
16,312,000,000
13,927,000,000
12,701,000,000
13,023,000,000
17,319,000,000
17,411,000,000
12,651,000,000
15,883,000,000
17,067,000,000
13,290,000,000
12,752,000,000
10,216,000,000
8,074,000,000
8,127,000,000
10,808,000,000
8,783,000,000
7,393,000,000
8,573,000,000
7,585,000,000
11,376,000,000
9,184,000,000
9,983,000,000
15,738,000,000
16,950,000,000
16,035,000,000
18,667,000,000
10,461,000,000
10,001,000,000
9,628,000,000
10,692,000,000
13,046,000,000
14,557,000,000
10,702,000,000
9,202,000,000
10,112,000,000
15,562,000,000
13,213,000,000
19,424,000,000
24,207,000,000
20,209,000,000
13,815,000,000
10,874,000,000
9,961,000,000
8,627,000,000
6,504,000,000
6,545,000,000
7,107,000,000
5,924,000,000
4,126,000,000
5,144,000,000
4,018,000,000
6,950,000,000
13,609,000,000
3,925,000,000
4,051,000,000
3,592,000,000
4,459,000,000
3,146,000,000
3,733,000,000
5,372,000,000
5,714,000,000
4,938,000,000
2,323,000,000
3,647,000,000
3,563,000,000
4,024,000,000
7,473,000,000
4,445,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.